Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Argus Health
Chinese Patent Office
AstraZeneca
Cantor Fitzgerald
Deloitte
McKinsey
Daiichi Sankyo
Fuji
Johnson and Johnson

Generated: January 17, 2018

DrugPatentWatch Database Preview

MILNACIPRAN HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Milnacipran Hydrochloride patents expire, and when can generic versions of Milnacipran Hydrochloride launch?

Milnacipran Hydrochloride is a drug marketed by Amneal Pharms and Windlas Hlthcare and is included in two NDAs.

The generic ingredient in MILNACIPRAN HYDROCHLORIDE is milnacipran hydrochloride. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the milnacipran hydrochloride profile page.

US Patents and Regulatory Information for MILNACIPRAN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-001 Apr 22, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Windlas Hlthcare MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205071-003 Jan 27, 2016 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-004 Apr 22, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Windlas Hlthcare MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205071-004 Jan 27, 2016 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-002 Apr 22, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-003 Apr 22, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Windlas Hlthcare MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205071-002 Jan 27, 2016 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Windlas Hlthcare MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205071-001 Jan 27, 2016 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Julphar
Cerilliant
Chinese Patent Office
Covington
Farmers Insurance
Moodys
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot